Literature DB >> 17534638

Pathogenesis of sinus cholesteatoma.

Holger Sudhoff1, Mirko Tos.   

Abstract

UNLABELLED: The aim of the present study was to provide evidence for the establishment of sinus cholesteatoma, defined as postero-superior pars tensa retraction extending into the posterior tympanum and tympanic sinuses.
BACKGROUND: There is clinical evidence for formation of a retraction, but there is a lack of explanation for the transition from a retraction pocket to an active and expanding sinus cholesteatoma. Epidemiological studies on incidence of postero-superior retractions of pars tensa and follow-up studies on patients with similar pars tensa retractions were performed. Additionally, expression of proliferation marker and analysis of basement membrane were studied in samples of sinus cholesteatoma. The prevalence of pars tensa pathology was between 9.2 and 24% of investigated ears. In children with manifest secretory otitis there were some sinus cholesteatomas and 5-6% severe retractions, some of those became pre-cholesteatomas, requiring treatment and controls. Immunohistochemistry of sinus cholesteatomas showed that proliferating keratinocytes were very often found within epithelial cones growing towards the underlying stroma. These growth cones exhibit focal discontinuities of the basement membrane especially in areas of intense subepithelial inflammation. As a possible explanation based on clinical and immunohistochemical findings, we propose a four-step concept for pathogenesis of sinus cholesteatoma combining the retraction and proliferation theory: (1) The retraction pocket stage. (2) The proliferation stage of the retraction pocket, subdivided in (a) Cone formation, (b) Cone fusion. (3) Expansion stage of attic cholesteatoma. (4) Bone resorption.

Entities:  

Mesh:

Year:  2007        PMID: 17534638     DOI: 10.1007/s00405-007-0340-y

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   3.236


  19 in total

Review 1.  Bone resorption in chronic otitis media: the role of the osteoclast.

Authors:  Jae Y Jung; Richard A Chole
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  2002 Mar-Apr       Impact factor: 1.538

2.  Pathogenesis and surgical treatment of the middle ear cholesteatoma.

Authors:  L Rüedi
Journal:  Acta Otolaryngol Suppl       Date:  1979

3.  A cohort study of point prevalence of eardrum pathology in children and teenagers from age 5 to age 16.

Authors:  S E Stangerup; M Tos; R Arnesen; P Larsen
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

4.  Basement membrane in middle ear cholesteatoma. Immunohistochemical and ultrastructural observations.

Authors:  H Sudhoff; J Bujía; G Borkowshi; C Koc; A Holly; H Hildmann; A Fisseler-Eckhoff
Journal:  Ann Otol Rhinol Laryngol       Date:  1996-10       Impact factor: 1.547

5.  Angiogenesis and angiogenic growth factors in middle ear cholesteatoma.

Authors:  H Sudhoff; S Dazert; A M Gonzales; G Borkowski; S Y Park; A Baird; H Hildmann; A F Ryan
Journal:  Am J Otol       Date:  2000-11

6.  Pathogenesis of attic cholesteatoma: clinical and immunohistochemical support for combination of retraction theory and proliferation theory.

Authors:  H Sudhoff; M Tos
Journal:  Am J Otol       Date:  2000-11

7.  Osteoclast stimulating and differentiating factors in human cholesteatoma.

Authors:  Michael Hamzei; Giovanni Ventriglia; Mitra Hagnia; Alexandra Antonopolous; Manuel Bernal-Sprekelsen; Stefan Dazert; Henning Hildmann; Holger Sudhoff
Journal:  Laryngoscope       Date:  2003-03       Impact factor: 3.325

8.  Ear polyps in posterior superior retraction pockets, herodion. Histopathological and pathogenetic aspects.

Authors:  P L Larsen; M Tos
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  1992       Impact factor: 1.538

9.  Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections.

Authors:  G Cattoretti; M H Becker; G Key; M Duchrow; C Schlüter; J Galle; J Gerdes
Journal:  J Pathol       Date:  1992-12       Impact factor: 7.996

10.  Expression of matrix-metalloproteinases and their inhibitors in human cholesteatomas.

Authors:  M Schönermark; B Mester; H G Kempf; J Bläser; H Tschesche; T Lenarz
Journal:  Acta Otolaryngol       Date:  1996-05       Impact factor: 1.494

View more
  9 in total

Review 1.  [Principles of cholesteatoma surgery].

Authors:  T Stark; A Gurr; H Sudhoff
Journal:  HNO       Date:  2011-04       Impact factor: 1.284

2.  A new theory interprets the development of a retraction pocket as a natural self-healing process.

Authors:  Karl-Bernd Hüttenbrink
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-12-12       Impact factor: 2.503

3.  The contralateral ear in cholesteatoma.

Authors:  Sady Selaimen da Costa; Adriane Ribeiro Teixeira; Letícia Petersen Schmidt Rosito
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-07-30       Impact factor: 2.503

4.  Role of Eustachian Dysfunction and Primary Sclerotic Mastoid Pneumatisation Pattern in Aetiology of Squamous Chronic Otitis Media: A Correlative Study.

Authors:  Shraddha Jain; Pragya Singh; Disha Methwani; Sanika Kalambe
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-02-05

Review 5.  Animal models of middle ear cholesteatoma.

Authors:  Tomomi Yamamoto-Fukuda; Haruo Takahashi; Takehiko Koji
Journal:  J Biomed Biotechnol       Date:  2011-04-06

6.  The Role of Tympanic Membrane Retractions in Cholesteatoma Pathogenesis.

Authors:  Letícia Petersen Schmidt Rosito; Neil Sperling; Adriane Ribeiro Teixeira; Fábio André Selaimen; Sady Selaimen da Costa
Journal:  Biomed Res Int       Date:  2018-02-21       Impact factor: 3.411

7.  RhoA, ROCK-1, and ROCK-2 Gene Expression and Polymorphisms in Cholesteatoma Patients.

Authors:  Kemal Görür; Kansu Büyükafşar; Etem Akbaş; Onur İsmi; Duygu Yolal Ertural; Ayşegül Çetinkaya
Journal:  J Int Adv Otol       Date:  2021-11       Impact factor: 1.017

8.  Identification of novel cholesteatoma-related gene expression signatures using full-genome microarrays.

Authors:  Christin Klenke; Sebastian Janowski; Daniela Borck; Darius Widera; Jörg Ebmeyer; Jörn Kalinowski; Anke Leichtle; Ralf Hofestädt; Tahwinder Upile; Christian Kaltschmidt; Barbara Kaltschmidt; Holger Sudhoff
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

9.  Large-scale proteomics differentiates cholesteatoma from surrounding tissues and identifies novel proteins related to the pathogenesis.

Authors:  Anders Britze; Rune Isak Dupont Birkler; Niels Gregersen; Therese Ovesen; Johan Palmfeldt
Journal:  PLoS One       Date:  2014-08-05       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.